TARGETED GENETICS (NASDAQ:TGEN)
0.23
0.02 (8%)
| TARGETED GENETICS (NASDAQ:TGEN) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $0.25 | 52 Week High | $0.70 | ||
| Open | $0.26 | 52 Week Low | $0.06 | ||
| Day High | $0.26 | P/E | N/A | ||
| Day Low | $0.23 | EPS | $-0.24 | ||
| Volume | 134,501 | ||||
| More TGEN Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| APOL | 2 | LVS | 2 |
| BGP | 2 | OSK | 2 |
| CELG | 2 | TISI | 2 |
| HLYS | 2 | ZOLL | 2 |
| ZZ | 2 | HYTM | 2 |
| RACK | 1 | BA | 1 |
Entities who have mentioned TGEN
- 13D | View Related Stories »
- 13G | View Related Stories »
- Citi | View Related Stories »
- JPMorgan | View Related Stories »
- Goldman Sachs | View Related Stories »
- Morgan Stanley | View Related Stories »
- Wachovia | View Related Stories »
- Robert W Baird | View Related Stories »
- Banc of America | View Related Stories »
- BB&T Capital Markets | View Related Stories »
- Dividend | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Layoffs | View Related Stories »
- After-Hours Movers | View Related Stories »
- Goldman Sachs Conviction Buy List | View Related Stories »
- Goldman Sachs Conviction Sell List | View Related Stories »
- Deutsche Bank | View Related Stories »
- UBS | View Related Stories »
View All ReportsStreetInsider.com Reports on TGEN
- Targeted Genetics (TGEN) Sells Certain Manufacturing Assets to Genzyme Corp (GENZ)
- Targeted Genetics (TGEN) Receives Non-Compliance Notification From NASDAQ
- Morning Movers 4/1: ZZ, SOA, MV, PDO, HYTM Higher; SGIC, SAH, TGEN, TISI, ZOLL, CELG Lower
- After-Hours Movers 3/31: LVS, BGP, HYTM, ZZ Higher; ZOLL, HLYS, BW, CELG, TISI, OSK Lower
- Targeted Genetics (TGEN) Reports A Q4 Loss of 54c
View All Press ReleasesCompany Press Releases on TGEN
- Targeted Genetics Corporation Reports Third Quarter 2009 Financial Results
- Nasdaq Grants Targeted Genetics Corporation an Extension to Regain Compliance With Continued Listing Requirements
StreetInsider Reports on TGEN by Category
View All BlogsBlogs on TGEN
- Biotech Busy with Bevy of Small Deals
- Analyst initiations: TGEN, TSCDY and NCTY
- Targeted Genetics: Timeline of Key Catalysts
- Targeted Genetics: Focused on Restoring Investor Confidence
View All FilingsSEC Filings on TGEN
- Form 10-Q TARGETED GENETICS CORP For: Sep 30
- Form 8-K TARGETED GENETICS CORP For: Nov 16
- Form SC 13G TARGETED GENETICS CORP Filed by: MARXE AUSTIN W & GREENHOUSE DAVID M
- Form 8-K TARGETED GENETICS CORP For: Nov 05
- Form 4 TARGETED GENETICS CORP For: Oct 09 Filed by: MARXE AUSTIN W & GREENHOUSE DAVID M
Comments on TGEN
No comments are currently available.
